Is Archrock Inc. (AROC) a Buy as Wall Street Analysts Look Optimistic?

Archrock Inc. (AROC) has an average brokerage recommendation (ABR) of 1.50, approximating a rating between Strong Buy and Buy, based on ratings from eight brokerage firms. However, the article suggests investors should be cautious about relying solely on brokerage recommendations due to inherent biases, noting that analysts are often overly optimistic. Furthermore, the Zacks Consensus Estimate for Archrock's current year earnings has declined 2% over the past month to $1.62, leading to a Zacks Rank #4 (Sell) for the stock, suggesting potential near-term price declines.

Analysis

Archrock Inc. (AROC) presents a conflicting investment picture based on different analytical methodologies highlighted in the report. On one hand, the company holds an Average Brokerage Recommendation (ABR) of 1.50, derived from eight brokerage firms, which positions it between a Strong Buy and Buy. Specifically, five analysts rate it a Strong Buy (62.5%) and two rate it a Buy (25%). However, the article cautions against relying solely on such sell-side recommendations, citing inherent positive biases and a historical lack of predictive success. Contrasting this, the Zacks Rank, a proprietary model focused on earnings estimate revisions, assigns AROC a #4 (Sell). This downgrade is attributed to a 2% decline in the Zacks Consensus Estimate for Archrock's current year earnings to $1.62 over the past month, signaling growing pessimism among analysts regarding the company's earnings prospects and suggesting potential for near-term stock price declines. The article emphasizes the stronger correlation empirical research shows between earnings estimate revisions and near-term stock price movements, implying the Zacks Rank offers a more timely and potentially reliable indicator than the ABR for AROC.

Key Decisions for Investors

• Investors should exercise caution regarding the optimistic Average Brokerage Recommendation for Archrock Inc. (AROC) and not solely base investment decisions on it.
• The recent 2% decline in the current year's consensus earnings per share estimate to $1.62 and the resulting Zacks Rank #4 (Sell) for AROC signal potential near-term headwinds and should be considered significant risk factors.
• It is advisable to prioritize the trend in earnings estimate revisions and the Zacks Rank over the ABR when assessing AROC's investment potential, and potentially re-evaluate or reduce exposure given the negative revisions and Sell rating.